The need for worldwide policy and action plans for rare diseases by Forman, John, Taruscio, Domenica, Llera, Virginia A., Barrera, Luis A., Coté, Timothy R., Edfjäll, Catarina, Gavhed, Désirée, Haffner, Marlene E., Nishimura, Yukiko, Posada, Manuel, Tambuyzer, Erik, Groft, Stephen C., Henter, Jan-Inge

Get full text

Does orphan drug legislation really answer the needs of patients? by Haffner, Marlene E, Dr, Torrent-Farnell, Josep, MD, Maher, Paul D, MD

Get full text

The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development by Tambuyzer, Erik T, Handelin, Barbara L, Basile, Richard A, Haffner, Marlene E

Get full text

Developing treatments for inborn errors: incentives available to the clinician by Haffner, Marlene E

Get full text

The Current Environment in Orphan Drug Development by Haffner, Marlene E.

Get full text

Orphan Drug Development — International Program and Study Design Issues by Haffner, Marlene E.

Get full text

Orphan Drugs: The United States Experience by Haffner, Marlene E.

Get full text

Designing Clinical Trials to Study Rare Disease Treatment by Haffner, Marlene E.

Get full text

The United States Orphan Drug ACT: Challenges and Success by Haffner, Marlene E.

Get full text

Studies Involving Orphan Products for Treating/Diagnosing Women's Diseases by Haffner, Marlene E.

Get full text

Orphan products: origins, progress, and prospects by Haffner, M E

Get full text

Orphan Products—Ten Years Later and Then Some by Haffner, Marlene E.

Get full text

Evaluation of Orphan Products by the U.S. Food and Drug Administration by Haffner, Marlene E., Kelsey, John V.

Get full text

Food and Drug Administration warning on dead space in tracheal tubes by Haffner, M E

Get full text

Breathing frequency monitors by Gluck, Michael S., Haffner, Marlene E.

Get full text